Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
Health
Aveek Bhowmik

Elon Musk’s Brain Chip Company Gets FDA Greenlight For ‘First-In-Human Clinical Study’

Neuralink logo displayed on mobil with founder Elon Musk seen on screen in the background. Neuralink Corporation is a neurotechnology company that develops implantable brain-computer interfaces. In Brussels on 4 December 2022. JONATHAN RAA/BENZINGA

Elon Musk’s brain-implant company Neuralink has received a green light from the Food and Drug Administration to commence its “first-in-human clinical study.”

This milestone achievement for Neuralink comes after a series of setbacks and challenges faced by the company in its pursuit of FDA approval.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.